Feliferon (interferon) injection solution, 2,5 ml * 5 pcs
Release form, composition and packaging
Solution for injection is colorless, transparent or slightly opalescent.
Structure
1 ml contains feline interferon 400,000 IU as an active ingredient.
Excipients: glacial acetic acid – about 0.0045 ml (until the pH reaches 4.5 to 5), sodium acetate – 1.64 mg, sodium chloride – 5.84 mg, polysorbate 20 – 0.1 mg, sodium EDTA salt – 0.07 mg, dextran 40 – 50 mg , water d / i – up to 1 ml.
Packaged in 2.5 ml glass vials with a volume of 3 ml, sealed with rubber stoppers, reinforced with aluminum caps. The drug is packaged in 2 or 5 vials in a Corex lodgement, which is individually placed in cardboard boxes with instructions for use.
Pharmacological (biological) properties and effects
Feliferon® injection has antiviral and immunostimulating effects.
The mechanism of action consists in suppressing the reproduction of DNA and RNA-containing viruses in infected cells, increasing the resistance of healthy cells of the body to infection with viruses, increasing the phagocytic activity of macrophages and increasing the specific cytotoxicity of lymphocytes.
Feliferon® in terms of the degree of impact on the body belongs to low-hazard substances (hazard class 4 according to GOST 12.1.007-76), in recommended doses it does not have skin-irritating and resorptive-toxic effects.
Indications for the use of the drug
For therapeutic and prophylactic purposes for cats:
with gastrointestinal diseases;
with acute respiratory diseases;
other diseases of viral or viral-bacterial etiology.
Application procedure
Feliferon® solution for injection is administered intramuscularly.
For prophylactic purposes (in case of a threat of infection), the drug is prescribed in a dose of 200,000 IU per animal, twice with an interval of 48 hours.
For the treatment of viral, bacterial and mixed diseases of cats – the drug is administered in a daily dose of 200,000 IU for 5-7 days in combination with antibiotics, serum and immunoglobulin drugs, in accordance with the instructions for their use.
In severe cases of the disease and mixed infections, the average therapeutic dose is recommended to be doubled – 400,000 IU.
The peculiarities of the action of the drug during the first use or upon withdrawal have not been established.
Avoid missing the next dose of the drug, because this can lead to a decrease in therapeutic efficacy. If one dose is missed, it is necessary to enter it as soon as possible, then the interval between injections of the drug does not change.
Side effects
There are no side effects and complications when using the drug Feliferon® solution for injection in accordance with the instructions. With increased individual sensitivity and the appearance of allergic reactions, the drug should be canceled and antihistamines and symptomatic therapy should be prescribed to the animal.
Overdose symptoms with the use of the drug were not identified.
Contraindications to the use of FELIFERON® INJECTION SOLUTION
– individual hypersensitivity of the animal to interferons (including history);
– severe allergic and autoimmune diseases.
It is not recommended to use the drug Feliferon® solution for injection after vaccination of animals within 10 days.
Special instructions and measures for personal prevention
Feliferon® solution for injection is not allowed to be mixed in the same syringe with other medicinal products. Joint use with any chemotherapeutic and immunobiological agents (serum and immunoglobulin) is allowed.
Feliferon® injection is not intended for use in productive animals.
Personal prevention measures
When working with the drug, you should follow the general rules of personal hygiene and safety measures provided for when working with drugs.
In case of accidental contact of the drug with the skin or mucous membranes of the eyes, they should be rinsed with plenty of running water. People with hypersensitivity to the components of the drug should avoid direct contact with the drug Feliferon® injection. In case of allergic reactions or in case of accidental ingestion of the drug into the human body, you should immediately contact a medical institution (you should have instructions for using the drug or a label with you).
It is forbidden to use empty containers from under the medicinal product for domestic purposes, it must be disposed of with household waste.
Terms and conditions of storage
The drug should be stored in the manufacturer’s sealed packaging, protected from direct sunlight, out of reach of children, separately from food and feed at a temperature of 2 ° to 8 ° C. Single freezing to a temperature of -25 ° C is allowed. The shelf life of the medicinal product, subject to storage conditions in a sealed package, is 2 years from the date of manufacture, after opening the bottle – no more than 5 days. It is forbidden to use the drug after the expiration date.